Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Dobutamine Stress Echocardiography in the Diagnosis of Severe Aortic Stenosis in Patients With Low-flow Low-gradient and Co-exiting Wild-type Transthyretin Amyloid Cardiomyopathy

NCT06372301 is registered in ClinicalTrials.gov with Steen Hvitfeldt Poulsen as lead sponsor.

NCT NCT06372301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06372301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Dobutamine Stress Echocardiography in the Diagnosis of Severe Aortic Stenosis in Patients With Low-flow Low-gradient and Co-exiting Wild-type Transthyretin Amyloid Cardiomyopathy
Lead sponsor
Steen Hvitfeldt Poulsen
Phase
Not applicable
Overall status
Completed
Start date
April 2, 2024
Completion date
March 16, 2026
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, transthyretin amyloid cardiomyopathy